Table 2.
Overall (n = 755) | Apr./06-Sep./06 (n = 197) | Oct./06-Mar./07 (n = 225) | Apr./07-Sep./07 (n = 185) | Oct./07-Mar./08 (n = 148) | p Value | |
---|---|---|---|---|---|---|
Age (median: yrs) | 71 (41–90) | 71 (46–94) | 72 (41–85) | 71 (46–91) | 71 (44–90) | 0.61a |
PSA (median: ng/mL) | 7.6 (0.3-5490) | 7.6 (0.3–475) | 7.6 (0.58–196) | 7.2 (0.57–5490) | 7.7 (1.0–864) | 0.52a |
No. of cores (median) | 10 (6–12) | 10 (6–12) | 10 (6–12) | 10 (6–12) | 10 (6–12) | 0.08a |
GS 6 (%) | 14.6 (n = 110) | 17.2 (n = 34) | 13.3 (n = 30) | 11.9 (n = 22) | 16.2 (n = 24) | 0.51b |
GS 3 + 4 (%) | 11.1 (n = 84) | 9.1 (n = 18) | 12.0 (n = 27) | 11.4 (n = 27) | 8.1 (n = 12) | 0.13b |
GS 4 + 3 (%) | 8.1 (n = 61) | 5.6 (n = 11) | 8.9 (n = 20) | 7.0 (n = 13) | 11.5 (n = 17) | 0.23b |
GS 8–10 % | 6.6 (n = 50) | 8.6 (n = 17) | 6.2 (n = 14) | 5.9 (n = 11) | 5.4 (n = 8) | 0.64b |
PSA Prostate specific antigen, GS Gleason score
aKruskal-wallis test. bchi-square test